Design, Development And In Vitro Characterization of A Sensitive Nanoparticles Drug Delivery System for Targeted Delivery of An Anticancer Drug

Abstract

Cancer chemotherapy has limitations to its therapeutic effectiveness including lack of specificity of drug distribution, systemic toxicity, low bioavailability and multidrug resistance. Stimuli-sensitive nanoparticle drug delivery systems have emerged as a promising solution to these issues, allowing for the targeted and controlled delivery of anticancer drugs. These intelligent nanoparticles are crafted to react to various internal stimuli like pH levels, redox conditions, and enzymatic activity, as well as external factors such as temperature, light, and magnetic fields. This is due to the fact that this capability enables the precise release of drugs within the tumor microenvironment. The review offers a thorough account of how stimuli-sensitive nanoparticle drug delivery systems have been designed, developed, and characterized in vitro, all with the goal of delivering drugs to targeted animals for cancer treatment. Types of nanoparticles, fabrication, design considerations, in vitro assessment of their physicochemical and biological characteristics are reviewed and recent advances in the area discussed as well. The review highlights the current issues and future perspectives concerning the clinical transfer of smart nanoparticle systems emphasizing on their potential to positively influence therapeutic effects and to decrease the adverse effects.

Keywords

Introduction

Despite remarkable advancements in cancer diagnosis and treatment, it remains one of the leading causes of death worldwide. The traditional anticancer chemotherapy is commonly linked to significant drawbacks, including low aqueous solubility, non-specific biodistribution, rapid systemic clearance, dose-limiting toxicity, and multidrug resistance. Such obstacles considerably decrease the therapeutic effect and amplify the negative impact on healthy tissues, and thus, the necessity to use more sophisticated drug delivery methods that could enhance the treatment results is evident.(Mir, M. A., Akhter, M. H., Afzal, O., Rab, S. O., Altamimi, A. S., Alossaimi, M. A., ... & Ali, 2023)

It is now recognized that Nanoparticle-based drug delivery systems (NDDS) are one of the methods that can overcome the limitations of traditional chemotherapy. With their small size (less than a micron) and large surface area, nanoparticles can be fine-tuned to improve drug solubility, shield therapeutic agents from early degradation, and control drug release. Moreover, the enhanced permeability and retention (EPR) effect enables nanoparticles to selectively accumulate in tumors, aiding in passive targeting and reducing systemic toxicity.

In recent years, there has been a growing interest in using stimuli-sensitive (smart) nanoparticle drug delivery systems for targeted cancer treatment. These systems are built to respond to specific internal stimuli (like pH, redox potential, or enzymatic activity) or external factors (such as temperature, light, magnetic fields, and ultrasound). The acidic tumor microenvironment, with its high glutathione levels and overexpressed enzymes, makes the stimuli-responsive nanoparticles effective for drug release at specific sites. This responsiveness enhances the availability of drugs at the intracellular level while minimizing off-target effects. “(Abruzzo, A., Zuccheri, G., Belluti, F., Provenzano, S., Verardi, L., Bigucci, F., ... & Calonghi, 2016) "

Sensitive nanoparticle systems entail a lot of design and development whereby various formulation parameters such as choice of carrier material, particle size, surface charge, drug loading efficiency, and active targeting should be considered carefully. The biodegradable polymeric nanoparticles, lipid-based carriers and hybrid nanostructures have demonstrated a considerable potential in the anticancer application because of their biocompatibility and capability to degrade under controlled conditions. Newer research, such as design-of-experiment (DoE)-aided nanoparticle fabrication methods, has focused on the role of systematic optimization to formulate reproducible and efficient nanocarriers with desirable in vitro behavior.

In vivo studies are essential; hence, it is important to assess the appropriateness of nanoparticle drug delivery system by in vitro characterization before the in vivo studies. Parameters of importance that will inform the formulation stability, drug release behavior, as well as biological interactions will include size distribution, zeta potential, morphology, drug encapsulation efficiency, release kinetics, cytotoxicity, and cellular uptake. Thorough in vitro evaluation allows predicting the outcome of therapeutic work and further optimizing the results to achieve specific anticancer treatment. “(Hu, R., Zheng, H., Cao, J., Davoudi, Z., & Wang, 2017)"

This review focuses on the design, development, and in vitro assessment of stimuli-sensitive nanoparticle drug delivery systems aimed at targeting anticancer drugs specifically to cancer cells. It summarizes the current design approaches for nanoparticles, their fabrication, stimuli-responsive features, and in vitro measurement tools, while also detailing the existing challenges and viewpoints in the field of smart nanomedicine for cancer treatment.

2. Nanoparticle Drug Delivery Systems -In Cancer Therapy.

“It is well-established that nano-based drug delivery systems are a highly effective and versatile option for cancer treatment, as they can enhance the therapeutic index of anticancer drugs while reducing systemic toxicity. Unlike traditional drug preparations, nanoparticles are crafted by design at the nanostage (10-500nm), where factors such as size, surface charge, morphology, and surface functionality can be fine-tuned with precision to influence their physicochemical properties. The characteristics are crucial in defining the circulation time, cellular uptake, biodistribution, and drug release pattern.

One of the most significant advantages of using nanoparticle drug delivery systems for cancer treatment is their ability to improve drug solubility and stability. In most cases, anticancer agents have limited ability to be solubilized in water and are readily degraded in the biomolecular environment which restricts their usefulness in clinical environments. The presence of these drugs in nanoparticle carriers allows their protection against premature degradation, increases bioavailability, and allows the release of drugs to be sustained or controlled when at the tumor site.(Dang, Y., & Guan, 2020)

Nano-particles have the ability. The principle of passive targeting relies primarily on the enhanced permeability and retention (EPR) effect, which is due to the leaky blood vessels and incomplete lymphatic drainage found in tumor tissues. to attack tumors through active and passive systems. Passive targeting is grounded mainly on the enhanced permeability and retention (EPR) effect attributed to the leaky blood vessels and incomplete lymphatic drainage within tumor tissues. Depending on the size, nanoparticles are best indicated in tumor regions causing a high concentration of the drugs in the tumor regions than the normal tissues. The different outcomes of EPR in tumors of different types have, however, led to the creation of alternative methods in targeting.”

Direct targeting The surface of nanoparticles is actively modified by attaching ligands like antibodies, peptides, folic acid, transferrin, or aptamers that specifically target overexpressed receptors on cancer cells. This ligand-receptor interaction provides cells with an increased cell internalization process due to receptor-mediated endocytosis, which leads to improved drug and therapeutic effect delivery in the cell. This enables more specific treatment of cancer as well as minimising the off-target effects of such systems. “(Xin, Y., Yin, M., Zhao, L., Meng, F., & Luo, 2017)"

Also, nanoparticle drug delivery systems may be programmed to follow tumor microenvironment, and, therefore, the triggering of stimuli-sensitive drug delivery. Acidic pH, hypoxia, high enzyme activity, and redox potentials in cancer tissues are some of the characteristics that can be used to induce site-specific drug release. This method does not only increase the anticancer activity but also reduces the level of destruction of the healthy cells.

Besides drug delivery, nanoparticles may also be used in multifunctional applications to combine imaging agents, targeting moieties and therapeutic compounds into a single platform. Such theranostic nanoparticles enable diagnosis, treatment and monitoring of therapeutic response of cancer concurrently. Nanoparticle-based drug delivery systems are a revolutionary concept in cancer therapy as pointed out in the contemporary literature, which provide better precision, lower toxicity, and a higher response rate to treatment.(Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, 2022)

“Types of Nanoparticles Used For Anticancer Drug Delivery”

• Polymeric Nanoparticles: Stimuli-sensitive drug delivery Stimuli-sensitive drug delivery Polymeric nanoparticles are widely employed in stimuli-sensitive drug delivery because their physicochemical properties can be tailored and because they are biodegradable. The choice of polymer makes a final contribution to the rate of degradation, kinetic drug release and biocompatibility. In the present, pH-, redox-, or enzyme-responsive systems have been designed using polymers such as PLGA, PLA, chitosan and PEG-based copolymer. The other important aspect of design is that particle size of 50 to 200 nm is associated with a long circulation time and efficient tumor accumulation because the enhancement of permeability and retention effect results in the increase of specified particles. Surface alteration with polyethylene glycol (PEG) or tumor targeting ligands increases its further stability and selectivity against tumors. In addition to this, polymeric nanoparticles allow a high level of flexibility in the development of stimuli-responsive linkage, which could be to deliver drugs at the sites within the tumor microenvironment.
• Lipid-Based Nanoparticles: Lipid-based nanoparticles are modeled to be very similar to biological membranes, thereby being very biocompatible. Factors covered in design are some lipid composition, surfactant choice, and lipid phase behavior. Liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs) can be engineered to react to changes in pH or temperature in tumor tissues.  In SLNs, the crystal arrangement of solid lipids determines the drug loading and release, and NLCs is made of solid and liquid lipids in order to enhance the encapsulation rate. Targeting capability and circulation stability is increased by surface modification with ligands or polymers. A significant problem in the lipid-based systems is to ensure the stability of the formulation and obtain reproducible drug release.
• Metallic Nanoparticles: Metallic nanoparticles are non-biodegradable and may be toxic, therefore, they need to be designed very carefully. The materials like gold, iron oxide and silver are chosen on their sensitiveness to external influences such as lights, heat or magnetic fields. Of vital importance to biodistribution, cellular uptake, and clearance are particle size and surface coating. The polymers or biomolecules of interest must be functionalized with biocompatible polymers or biomolecules to enhance stability and decrease toxicity. Metallic nanoparticles have found special applications in stimuli-responsive and theranostic applications, but a long-term safety and accumulation in the important organs is a critical design consideration.
• Dendrimers: Dendrimers are highly branched in structure and offer numerous surface functional groups with which drug attachment and targeting ligand conjugation can be undertaken. Generation number, surface charge, and terminal group chemistry have a big impact on cytotoxicity and drug loading capacity. To achieve stimuli sensitive delivery, the dendrimers may be configured to have cleavable linkages that are sensitive to pH or redox conditions. Although dendrimers have accurate structural control and high drug payload, surface toxicity inherent by positively charged groups requires surface modification to increase biocompatibility.
• Mesoporous Silica Nanoparticles: Mesoporous silica nanoparticles are structured according to the pore size, surface area, and pore volume, the latter that have direct impacts on the drug loading and release characteristics. Polymers or molecular gatekeepers can be used as functionalization agents on surfaces to achieve stimuli-responsive drug release, based on the pH, enzymatic conditions, or redox conditions. Although they have a good loading capacity and structural stability, biodegradability issues and long-term toxicity have to be taken into consideration, and proper material engineering and surface modification approaches have to be considered to enhance clinical applicability.

3. Design Considerations For Stimuli-sensitive Nanoparticles

Particle size is essential in terms of the circulation time, cellular uptake, and tumor accumulation. The best nanoparticles to use the enhanced permeability and retention effect are those between 50 and 200 nm. To effectively develop such systems, it is necessary to have a deep understanding of the interactions among the characteristics of nanocarriers, the microenvironmental properties of tumors, and the chosen stimulus. Earlier studies on smart micro/nanoparticles have underscored the importance of rational design for achieving controlled drug release in specific spatiotemporal contexts and minimizing off-target toxicity.(Karimi, M., Ghasemi, A., Zangabad, P. S., Rahighi, R., Basri, S. M. M., Mirshekari, H., ... & Hamblin, 2016)

3.1 Selection of Stimulus

The design of stimulus is one of the key aspects of the design and it is going to be determined by the pathological characteristics of the tumor and the additional types of therapy it should be used with. Intrinsic to the tumor microenvironment are internal stimuli, e.g. acidic pH, increased glutathione concentrations, hypoxia, and excessively expressed enzymes, which permit the autonomous release of drugs. External factors like temperature, light, ultrasound, and magnetic fields can enhance control over drug release but require external equipment. By choosing the stimulus, selective activation of the nanoparticle system at the tumor site will be achieved.

3.2 Material Selection and Carrier Composition

The fabrication of nanoparticles is determined by the material directly affecting the biocompatibility, biodegradability, and stimulus responsiveness. Smart nanoparticles are normally constructed using polymers, lipids, inorganic materials, and hybrid systems. The materials should be able to undergo structural or chemical transformations of the selected stimulus without producing any toxic by-products. Preference is usually placed on biodegradable carriers to provide harmless disposition of the body.

3.3 Particle Size and Surface Characteristics

In this respect, good nanoparticles preparations to use in anticancer biomedical applications must be capable of high cytotoxicity in cancer cells and low cytotoxicity in normal cells. These tests also prove useful in finding the optimal drug concentration as well as exposure time. Cellular interaction and colloidal stability are influenced by surface charge; proteins that are bound to the surface tend to adsorb less nonspecifically on surfaces that are slightly negative or neutral. The stability and tumor selectivity are enhanced through surface modification with polyethylene glycol or targeting ligands.

3.4 Drug Loading and Release Mechanism

The stimuli-sensitive nanoparticles must have the key requirements of efficient drug loading and controlled release. Stimulus-cleavable linkers may be used to chemically conjugate drug molecules either physically or chemically. The release mechanism must provide a minimum drug release at normal physiological conditions and the release to be fast on being exposed to the particular stimulus. The design enhances the therapeutic efficacy and minimizes systemic toxicity.(Skirtach, A. G., & Kreft, 2009)

4. Development Methods of Nanoparticles

“Nanoparticle drug delivery systems (NPs) development is central to their physicochemical properties, biological functions, and therapeutic effects. Various fabrication methods have been explored to achieve a fine level of control over particle size, morphology, surface charge, drug encapsulation efficiency, and responsiveness to stimuli. The choice of a specific development method is influenced by several factors, including the characteristics of the anticancer drug, the makeup of the carrier material, the intended release kinetics, and the kind of internal or external trigger to be utilized. In the case of stimuli-sensitive nanoparticles, the development procedures should permit the proper inclusion of the responsive components with preserving the formulation stability and reproducibility.(Patil, N., Bhaskar, R., Vyavhare, V., Dhadge, R., Khaire, V., & Patil, 2021)

Among the various methods of producing polymeric nanoparticles, nanoprecipitation is one of the most commonly employed due to its simplicity, low energy requirements, and scalability. This process leads to the formation of nanoparticles due to the rapid diffusion of a polymer-drug solvent into the liquid phase. The method allows for the efficient encapsulation of hydrophobic anticancer agents and facilitates a clear representation of particle size distribution, making it well-suited for creating polymeric systems that respond to pH and redox changes. Likewise, the emulsion-solvent evaporation method is very suitable for use in both polymeric and lipid-based nanoparticles, especially when a high level of drug loading is required. The formulation conditions (such as surfactant concentration, homogenization rate, and solvent evaporation rate) can be altered to use this technique to control the properties of nanoparticles.

Ionic gelation is a solvent-free, rather mild, technique that is mainly applied to natural polymer nanoparticles, e.g., chitosan and alginate. It is a method based on the electrostatic reactions between oppositely charged polymers or crosslinking agents, which leads to the formation of nanoparticles at mild conditions. Due to its biocompatibility and minimal use of harsh chemicals, ionic gelation is particularly advantageous for enzyme- and pH-responsive drug delivery systems and the encapsulation of sensitive biomolecules. Conversely, lipid-based nanoparticles like liposomes, solid lipid nanoparticles, and nanostructured lipid carriers are commonly made using the thin-film hydration technique. The method has the benefit of flexibly adjusting lipid composition, allows high encapsulation efficiency, and allows surface modification with targeting ligands or stimuli-responsive molecules.(Zhang, G., Yin, R., Dai, X., Wu, G., Qi, X., Yu, R., ... & Jiang, 2022)

Nanoparticle fabrication has also been carried out using microemulsion-based methods because this method can generate uniform and nanosized particles with a low size distribution. These systems are thermodynamically perfect and enable the fine-tuning of the characteristics of particles with the help of the surfactant and co-surfactant concentration. Green synthesis methods have also been developed as a sustainable method of nanoparticle development, especially of metallic and polymeric nanoparticles. The techniques make use of solvents that are eco-friendly, reducing agents that are biological and energy-saving measures that minimize toxicity and environmental impact and enhance biocompatibility.

The concept of design of experiments (DoE) in nanoparticles development has received significant focus in the past few years. DoE offers a logical, statistical method of assaying the impact of numerous formulation as well as process factors at the same time. This is a methodology that allows one to learn about key considerations when it comes to nanoparticles and performance, including particle size, drug loading and release. Having formulations that are robust, reproducible, and scalable is necessary in the translation of stimuli-sensitive nanoparticle drug delivery systems previously tested in the laboratory to real clinical and industrial studies, which DoE-assisted development improves.(Hachem, K., Ansari, M. J., Saleh, R. O., Kzar, H. H., Al-Gazally, M. E., Altimari, U. S., ... & Kianfar, 2022)

5. In Vitro Characterization of Nanoparticles

In vitro characterization is a crucial step in the evaluation of nanoparticle drug delivery systems, as it provides vital information about their physicochemical properties, stability, drug-carrying capacity, and potential applications. These parameters are crucial for bio-performance, cellular uptake, and therapeutic efficacy. To estimate how stimuli-sensitive nanoparticles behave in vivo and to optimize formulation design for targeted anticancer therapy, comprehensive in vitro tests are necessary. (Dhand, C., Dwivedi, N., Loh, X. J., Ying, A. N. J., Verma, N. K., Beuerman, R. W., ... & Ramakrishna, 2015)

5.1 “Particle Size, Polydispersity Index (PDI), and Zeta Potential”

A nanoparticle's dimensions are crucial in ascertaining its biodistribution, circulation, cellular uptake, and tumor characteristics. It is asserted that nanoparticles sized between 50 and 200 nm are optimal for low-dose cancer drug delivery, as they efficiently utilize the enhanced permeability and retention effect. The homogeneity of the particle size distribution is assessed by the polydispersivity index (PDI), with lower PDI values indicating greater formulation homogeneity. Zeta potential serves as an important metric for assessing surface charge and colloidal stability. Nanoparticles exhibiting a sufficiently high positive or negative zeta potential tend to be more stable due to the electrostatic repulsion of particles, which reduces their aggregation during storage and circulation.

5.2 Morphological Evaluation (SEM, TEM, AFM)

The morphological characterization gives an idea on the shape, surface structure and the general architecture of nanoparticles. The scanning electron microscopy (SEM) is a common method that may be used to observe the size, shape, or the surface smoothness of particles at nanoscale. The transmission electron microscopy (TEM) is also popular. The atomic force microscopy (AFM) has provided more details on the surface topography and mechanical properties. Spherical nanoparticles with smooth surfaces are typically preferred in terms of uniformity and consistency of drug release and enhanced cellular uptake during anticancer uses.(De Jong, W. H., Carraway, J. W., & Geertsma, 2020)

5.3 Drug Loading and Encapsulation Efficiency

A nanoparticle's dimensions are crucial in ascertaining its biodistribution, circulation, cellular uptake, and tumor characteristics. It is asserted that nanoparticles sized between 50 and 200 nm are optimal for low-dose cancer drug delivery, as they efficiently utilize the enhanced permeability and retention effect. The homogeneity of the particle size distribution is assessed by the polydispersivity index (PDI), with lower PDI values indicating greater formulation homogeneity. Zeta potential serves as an important metric for assessing surface charge and colloidal stability. Nanoparticles exhibiting a sufficiently high positive or negative zeta potential tend to be more stable due to the electrostatic repulsion of particles, which reduces their aggregation during storage and circulation.

5.4 In Vitro Drug Release Studies

The in vitro drug release is done to assess the release kinetics and stimulus-responsive behavior of nanoparticles in simulated physiological and tumor conditions. Such studies are frequently conducted as dialysis bag methods or diffusion in various release media.” Stimuli-sensitive nanoparticles In this case, the drug release profiles are measured to compare under different conditions, including those of pH, temperature or redox environment to determine site-specific release behavior. Regulated and prolonged release of drugs at tumor-targeted conditions can be regarded as a desirable characteristic to improve anticancer efficacy with low systemic toxicity.(Hesaraki, S., Alizadeh, M., Nazarian, H., & Sharifi, 2010)

6. In Vitro Biological Evaluation

Before in vivo investigation, an in vitro biological assessment is an indispensable measure in determining the safety, functionality, and therapeutic capacity of nanoparticle drug delivery systems. The studies offer important details regarding cytotoxicity, cellular interaction, uptake mechanisms, and biocompatibility that enables the detection of the potential safety issues in the initial stages. In case of stimuli sensitive nanoparticles to be used in anticancer therapy, the biological test can be performed in vitro as a valid and moral method in predicting the biological response and avoiding the reliance of animals.(Ozturk, N., Kara, A., & Vural, 2021)

6.1 Selection of Cell Lines

The correct choice of cell lines forms the basis of assessing the biological functionality of nanoparticle preparations. The use of cancer cell lines that are of relevance to the target disease, like the cancer cell of breast, lung, colon, or liver, is very common in determining the efficacy of anticancer. Normal or healthy cell lines are as well added to test selective toxicity and biocompatibility. The efficiency and safety profile of the nanoparticle system using a comparative analysis of cancerous and non-cancerous cells can be determined.

6.2 Cytotoxicity Studies

One of the major parameters of biological evaluation is cytotoxicity, which is usually measured by colorimetric methods, e.g. MTT, XTT, or WST-1. These are assays that can determine cell viability after being exposed to nanoparticles, and give an understanding of dose-dependent toxicity. Within this framework, successful nanoparticle preparations for anticancer biomedical use must show strong cytotoxicity against cancer cells while maintaining low cytotoxicity in normal cells. These studies are also useful for identifying the optimal drug concentration and exposure duration.(Ahmadi, M., Madrakian, T., Ghoorchian, A., Kamalabadi, M., & Afkhami, 2020)

6.3 Cellular Uptake Studies

Studies about cellular uptake are done to determine the behaviour of nanoparticles upon taking them in target cells. Fluorescence microscopy, confocal laser scanning microscopy and flow cytometry are some of the most frequently used techniques to visualize and measure nanoparticle uptake. Enhanced cellular internalization means that nanoparticles interact well with cancer cells and this is necessary in intracellular drug delivery and treatment outcome. The uptake is greatly affected by the targeting ligands as well as surface modification.

6.4 Apoptosis and Cell Cycle Analysis

The mode of anticancer action of nanoparticle formulations is mechanistically understood in the work of apoptosis and cell cycle. The FLT assays based on flow cytometry are frequently applicable to measure the number of apoptotic cells and cell cycle changes. Programmed cell death and cell cycle arrest at certain stages are signs of efficient anticancer effect of the drug that is delivered by the nanoparticle. These experiments are used to enhance the cytotoxicity data and reinforce the biological evaluation results.(Yazdan, M., & Naghib, 2025)

6.5 Hemocompatibility and Biocompatibility Studies

The nanoparticle systems that are supposed to be transported through the systemic administration require hemocompatibility testing. The compatibility of nanoparticles with blood components is often evaluated by performing hemolysis assays and blood compatibility tests. Also, inflammatory responses, oxidative stress, and membrane integrity are studied during biocompatibility to make sure that the nanoparticle system does not cause the bad biological effects. Clinical translation requires favorable hemocompatibility and biocompatibility.

7. Recent Advances in Stimuli-sensitive Nanoparticles

“Within the recent years, a substantial progress has been made in the creation of stimuli-sensitive nanoparticle drug delivery systems, which are based upon the necessity of the accurate and targeted delivery of drugs to cancer cells and improving the therapeutic efficacy. The works in the sphere of material science and nanotechnology resulted in the possibility to create smart nanoparticles which respond to particular internal factors (pH, redox potential, enzymatic activity and hypoxia) and external factors (temperature, light, ultrasound or magnetic field). They are supposed to take advantage of the special features of the tumor microenvironment that increase the efficacy of intracellular drug delivery with reduced off-target toxicity.(Rahim, M. A., Jan, N., Khan, S., Shah, H., Madni, A., Khan, A., ... & Thu, 2021)

One significant future development of stimuli-sensitive nanoparticles is the introduction of multifunctional elements of design that incorporate targeting, imaging and therapy into a single platform. Selective accumulation of drugs and controlled release has been enhanced by surface modification with targeting ligands, stimuli-responsive polymers and cleavable linkers. In vitro analyses have shown that pH- and redox-responsive nanoparticles have higher rates of drug release under conditions that mimic tumors than those it does under physiological conditions resulting to greater cytotoxicity against cancer cells. These results indicate that stimulus-specific release could serve to enhance anticancer efficacy.

Recent literature also has focused on the use of high-end in vitro evaluation methods to determine the biological performance of smart nanoparticles. Stimuli-sensitive systems have been found to exhibit better cellular uptake, better induction of apoptosis and better intracellular drug accumulation in comparison to non-responsive counterparts. Moreover, three-dimensional cell culture models and co-culture systems have also offered greater physiologically relevant information about nanoparticle-cell interactions to fill the gap between traditional in vitro assays and in vivo functionality.(Al-Aizari, F. A., Ghabbour, H. A., Kheder, N. A., Soliman, S. M., Hassan, M. Z., Tasqeeruddin, S., & Mabkhot, 2024)

The use of systematic formulation optimization methods, like design of experiments (DoE) to improve the reproducibility and consistency of performance of stimuli-sensitive nanoparticles is another interesting development. These methods allow the determination of key parameters of formulations which drive the particle size, drug loading and stimulus responsiveness. Also, the advancement in green synthesis and biodegradable nanomaterials has resolved the safety and environmental issues related to the development of nanomedicine.

Altogether, the current developments of stimuli-sensitive nanoparticle systems highlight the fact that these systems can transform targeted anticancer drug delivery. Further optimization of nanoparticles design and effective in vitro testing plans is likely to promote successful transfer of these smart systems into clinically viable cancer therapies.(Taheri, M., Aslani, S., Ghafouri, H., Mohammadi, A., Akbary Moghaddam, V., Moradi, N., & Naeimi, 2022)

CONCLUSION

The stimulus sensitive nanoparticle drug delivery systems are a new kind of delivery system that is aimed to enhance effectiveness and safety of anticancer drugs. By incorporating the innovations in nanotechnology, material science, and formulation of drugs, these smart systems will be in a position to counter the significant drawbacks of traditional chemotherapy which include lack of specificity to the targeted cells, systemic toxicity, and lack of efficacy. The targeted delivery of drugs at the point of action can be achieved through selective response of the nanoparticles when they respond to internal tumor specific stimuli or when external stimuli is applied.

This review has emphasized the use of rational design and development strategies in developing stimuli-sensitive nanoparticles and this is with specific reference to the choice of material, the fabrication process and the optimization strategy. There is extensive in vitro characterization that involves physicochemical characterization, and biological characterization, which is vital in determining the performance, stability and safety of these systems. The in vitro testing methodologies have also had recent breakthroughs enhancing the knowledge of nanoparticle-cell interactions and stimulus-responsive behavior to enable more precise evaluation of nanoparticles before in vivo and clinical research.

In spite of the major advances, the problems of scalability of formulation, long-term safety, reproducibility, and regulatory approval are still present. The strategy to overcome these drawbacks, which will muster effective clinical translation, will be to implement standardized evaluation protocols, biodegradable materials, and systematic optimization strategies. Altogether, the stimuli-sensitive nanoparticle drug delivery systems have much potential in changing the targeted therapy of cancer and it can be anticipated that further studies in this area would help in the creation of more efficient, more personal, and safer methods of cancer therapy in the future.”

REFERENCES

1. Mir, M. A., Akhter, M. H., Afzal, O., Rab, S. O., Altamimi, A. S., Alossaimi, M. A., ... & Ali, M. S. (2023). Design-of-experiment-assisted fabrication of biodegradable polymeric nanoparticles: in vitro characterization, biological activity, and in vivo assessment. ACS omega, 8(42), 38806-38821.
2. Abruzzo, A., Zuccheri, G., Belluti, F., Provenzano, S., Verardi, L., Bigucci, F., ... & Calonghi, N. (2016). Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells. Colloids and Surfaces B: Biointerfaces, 145, 362-372.
3. Hu, R., Zheng, H., Cao, J., Davoudi, Z., & Wang, Q. (2017). Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems. Journal of biomedical nanotechnology, 13(9), 1097-1105.
4. Dang, Y., & Guan, J. (2020). Nanoparticle-based drug delivery systems for cancer therapy. Smart materials in medicine, 1, 10-19.
5. Xin, Y., Yin, M., Zhao, L., Meng, F., & Luo, L. (2017). Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer biology & medicine, 14(3), 228-241.
6. Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022). Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS applied bio materials, 5(3), 971-1012.
7. Karimi, M., Ghasemi, A., Zangabad, P. S., Rahighi, R., Basri, S. M. M., Mirshekari, H., ... & Hamblin, M. R. (2016). Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chemical society reviews, 45(5), 1457-1501.
8. Skirtach, A. G., & Kreft, O. (2009). Stimuli-sensitive nanotechnology for drug delivery. In Nanotechnology in drug delivery (pp. 545-578). New York, NY: Springer New York.
9. Patil, N., Bhaskar, R., Vyavhare, V., Dhadge, R., Khaire, V., & Patil, Y. (2021). Overview on methods of synthesis of nanoparticles. International Journal of Current Pharmaceutical Research, 13(2), 11-16.
10. Hachem, K., Ansari, M. J., Saleh, R. O., Kzar, H. H., Al-Gazally, M. E., Altimari, U. S., ... & Kianfar, E. (2022). Methods of chemical synthesis in the synthesis of nanomaterial and nanoparticles by the chemical deposition method: a review. BioNanoScience, 12(3), 1032-1057.
11. Dhand, C., Dwivedi, N., Loh, X. J., Ying, A. N. J., Verma, N. K., Beuerman, R. W., ... & Ramakrishna, S. (2015). Methods and strategies for the synthesis of diverse nanoparticles and their applications: a comprehensive overview. Rsc Advances, 5(127), 105003-105037.
12. De Jong, W. H., Carraway, J. W., & Geertsma, R. E. (2020). In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. In Biocompatibility and performance of medical devices (pp. 123-166). Woodhead Publishing.
13. Hesaraki, S., Alizadeh, M., Nazarian, H., & Sharifi, D. (2010). Physico-chemical and in vitro biological evaluation of strontium/calcium silicophosphate glass. Journal of Materials Science: Materials in Medicine, 21(2), 695-705.
14. Ozturk, N., Kara, A., & Vural, I. (2021). Evaluation of Stimuli-Sensitive Nanoparticles in vitro. In Drug Delivery with Targeted Nanoparticles (pp. 147-190). Jenny Stanford Publishing.
15. Ahmadi, M., Madrakian, T., Ghoorchian, A., Kamalabadi, M., & Afkhami, A. (2020). Stimuli-sensitive drug delivery systems. In Nanoengineered biomaterials for advanced drug delivery (pp. 37-59). Elsevier.
16. Yazdan, M., & Naghib, S. M. (2025). Smart ultrasound-responsive polymers for drug delivery: An overview on advanced stimuli-sensitive materials and techniques. Current Drug Delivery, 22(3), 283-309.
17. Rahim, M. A., Jan, N., Khan, S., Shah, H., Madni, A., Khan, A., ... & Thu, H. E. (2021). Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting. Cancers, 13(4), 670.
18. Al-Aizari, F. A., Ghabbour, H. A., Kheder, N. A., Soliman, S. M., Hassan, M. Z., Tasqeeruddin, S., & Mabkhot, Y. N. (2024). Synthesis, X-ray structure analysis, computational investigations, and in vitro biological evaluation of new thiazole-based heterocycles as possible antimicrobial agents. Polycyclic Aromatic Compounds, 44(1), 261-274.
19. Taheri, M., Aslani, S., Ghafouri, H., Mohammadi, A., Akbary Moghaddam, V., Moradi, N., & Naeimi, H. (2022). Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells. BMC chemistry, 16(1), 7.
20. Zhang, G., Yin, R., Dai, X., Wu, G., Qi, X., Yu, R., ... & Jiang, T. (2022). Design, synthesis, and biological evaluation of novel 7-substituted 10, 11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry, 241, 114610